Acumen Pharmaceuticals, Inc. (ABOS): Price and Financial Metrics

Acumen Pharmaceuticals, Inc. (ABOS): $1.07

0.06 (+5.94%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add ABOS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#176 of 301

in industry

ABOS Price/Volume Stats

Current price $1.07 52-week high $3.92
Prev. close $1.01 52-week low $0.86
Day low $1.00 Volume 165,300
Day high $1.09 Avg. volume 245,370
50-day MA $1.10 Dividend yield N/A
200-day MA $1.94 Market Cap 64.81M

ABOS Stock Price Chart Interactive Chart >


Acumen Pharmaceuticals, Inc. (ABOS) Company Bio


Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.


ABOS Latest News Stream


Event/Time News Detail
Loading, please wait...

ABOS Latest Social Stream


Loading social stream, please wait...

View Full ABOS Social Stream

ABOS Price Returns

1-mo N/A
3-mo N/A
6-mo -55.23%
1-year -70.68%
3-year -69.16%
5-year N/A
YTD -37.79%
2024 -55.21%
2023 -28.89%
2022 -20.12%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!